This retrospective study can serve as the basis of a large prospective cohort to determine whether UAD indices can predict adverse obstetric outcomes in women with fibroids and whether PAPP-A levels in the presence of fibroids can truly provide a clinically significant prediction of obstetric outcomes. The gene discussed is PAPPA; the disease is urethra adenocarcinoma.